Directed by Morcous Adel, In Broad Daylight recently went on release in Egypt and other territories in the region, marking a rare attempt by a Hollywood actor to break out in the Arab film industry
While there's no peer-reviewed data on why this happens, according to Rob Stransky, president of the telehealth provider NiceRx, this can happen because of how these drugs slow the body's gastric emptying process, or how food moves away from the stomach into the small intestine
Patients using off-label Ozempic for weight management a significant share of Canadian GLP-1 users will see the price benefit on the same timeline as diabetes patients
Prices may also vary by dosage and quantity prescribed
Suitable candidates include: Patients with type 2 diabetes and a BMI of 35 kg/m or higher (or 32.5 kg/m or higher for people of South Asian or other minority ethnic backgrounds), or where weight loss would benefit other significant obesity-related comorbidities Those with type 2 diabetes who have not achieved target HbA1c levels with metformin and other oral medications People for whom weight loss would benefit other obesity-related comorbidities or where weight-neutral treatment options are preferred Individuals with occupational implications where insulin therapy would be problematic Importantly, NICE recommends continuing GLP-1 receptor agonist treatment only if there is a beneficial metabolic response: after 6 months, treatment should continue only if HbA1c has decreased by at least 11 mmol/mol (1.0%) and weight has decreased by at least 3% from initial body weight

Taken together, these clinical trial data of semaglutide pharmacotherapy for body weight reduction showcase the broad opportunities afforded by proteomic analyses, including offering insights into mechanisms of action and potential novel indications to be tested in clinical studies